JPWO2023105976A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023105976A5 JPWO2023105976A5 JP2023566151A JP2023566151A JPWO2023105976A5 JP WO2023105976 A5 JPWO2023105976 A5 JP WO2023105976A5 JP 2023566151 A JP2023566151 A JP 2023566151A JP 2023566151 A JP2023566151 A JP 2023566151A JP WO2023105976 A5 JPWO2023105976 A5 JP WO2023105976A5
- Authority
- JP
- Japan
- Prior art keywords
- phase
- clinical test
- dementia
- scores
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 description 9
- 206010012289 Dementia Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 3
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 102000009190 Transthyretin Human genes 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021199612 | 2021-12-08 | ||
| JP2022118300 | 2022-07-25 | ||
| PCT/JP2022/040265 WO2023105976A1 (ja) | 2021-12-08 | 2022-10-27 | 臨床試験支援装置、臨床試験支援装置の作動方法、および臨床試験支援装置の作動プログラム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023105976A1 JPWO2023105976A1 (https=) | 2023-06-15 |
| JPWO2023105976A5 true JPWO2023105976A5 (https=) | 2024-08-22 |
Family
ID=86730104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566151A Pending JPWO2023105976A1 (https=) | 2021-12-08 | 2022-10-27 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US12614615B2 (https=) |
| JP (1) | JPWO2023105976A1 (https=) |
| WO (1) | WO2023105976A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358353B2 (en) | 2000-08-22 | 2008-04-15 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| JP2007524361A (ja) * | 2003-02-10 | 2007-08-30 | アジェンシス， インコーポレイテッド | 膀胱癌及びその他の癌の治療及び検出に有用な名称１５８ｐ１ｄ７の核酸及び対応タンパク質 |
| EP2227766A2 (en) * | 2007-11-05 | 2010-09-15 | Wista Laboratories Ltd. | Systems for clinical trials |
| US9834575B2 (en) | 2013-02-26 | 2017-12-05 | Triact Therapeutics, Inc. | Cancer therapy |
| US20160367620A1 (en) * | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
| US11139051B2 (en) * | 2018-10-02 | 2021-10-05 | Origent Data Sciences, Inc. | Systems and methods for designing clinical trials |
| CN114080646A (zh) | 2019-07-26 | 2022-02-22 | 富士胶片株式会社 | 信息处理装置、程序、学习完毕模型、诊断支援装置、学习装置及预测模型的生成方法 |
| US12593971B2 (en) * | 2021-11-18 | 2026-04-07 | Iterative Scopes, Inc. | Systems for tracking disease progression in a patient |
-
2022
- 2022-10-27 JP JP2023566151A patent/JPWO2023105976A1/ja active Pending
- 2022-10-27 WO PCT/JP2022/040265 patent/WO2023105976A1/ja not_active Ceased
-
2024
- 2024-05-24 US US18/673,319 patent/US12614615B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Denning et al. | Pediatric robotic surgery | |
| Beylin et al. | Higher mean arterial pressure with or without vasoactive agents is associated with increased survival and better neurological outcomes in comatose survivors of cardiac arrest | |
| Obert et al. | Effect of aerobic training and detraining on left ventricular dimensions and diastolic function in prepubertal boys and girls | |
| Kim et al. | Adverse events associated with poor neurological outcome during targeted temperature management and advanced critical care after out-of-hospital cardiac arrest | |
| Puthucheary et al. | Skeletal muscle mass and mortality-but what about functional outcome? | |
| Crowther et al. | Continuing challenges of sepsis research | |
| JPWO2023105976A5 (https=) | ||
| Morales-Amparano et al. | Impact of enolase in allergic disease | |
| Seshimo et al. | A case of anaphylactic shock induced by mealworm antigen in the bite of a Japanese flying squirrel. | |
| Frey et al. | A very mild phenotype in six individuals of a three‐generation family with the novel HRAS variant c. 176C> G p.(Ala59Gly): Emergence of a new HRAS‐related RASopathy distinct from Costello syndrome | |
| Naslund | Lessons from the Swedish Obese Subjects Study: The effects of surgically induced weight loss on obesity comorbidity | |
| CN309958374S (zh) | 消毒器（医用干雾） | |
| Sen et al. | Classic Ehlers–Danlos syndrome in a son and father with a heart transplant performed in the father | |
| Agarwal et al. | A rare case of nephrotic syndrome:′ Nailed′ the diagnosis | |
| Ng | COVID–Resuming A New Norm | |
| Jain et al. | Ultrasound diagnosis of hemodynamic compromise in a patient with hepatic hydrothorax | |
| Aremu et al. | Putting the spotlight on opisthorchiasis: the dread of the western Siberian region | |
| Azarov et al. | Could dopamine be a silent killer? | |
| Thomas | Non-demographic factors associated with morbidity | |
| Al-Shaikhli et al. | Reading the Heart's Code: A Systematic Review of Artificial Intelligence in Electrocardiography, from Diagnostic Models to Ethical Challenges: Abdulwahhab M Al-shaikhli¹, Ahmed-lamin Gehani², Ruaa Alsanad³, Safia M Abdi⁴, Siham M Abdi⁵, Asim Ahmed⁶ | |
| Zhang et al. | Correlation between endothelial dysfunction, Rho-associated protein kinase activity, C-reactive protein and obstructive sleep apnoea syndrome in male patients | |
| Scholtz et al. | Korotkow. Listen and Learn! | |
| Phillips | Neck | |
| Saxena et al. | Pros and Cons of the Nuss-Procedure | |
| Deshong et al. | Predicted Impact of the 107G> A HFE Variant on Hereditary Hemochromatosis |